CFROI vs Economic ROI: A Clearer Picture of Company Performance?
04 - 05 Nov 2025
Amsterdam
Omaha Insights
Bryant Matthews
Bryant Matthews
CEO & Head of Research
Bryant has a distinguished career in finance, having served as the Global Director of HOLT Research at Credit Suisse for over 25 years, where he developed innovative valuation models and advanced the HOLT framework, alongside contributions to research on profitability and growth. Bryant holds an MBA in Finance and Strategy from Northwestern University’s Kellogg School of Management and is currently pursuing a Master’s in Mathematics with a focus on Applied Statistics at DePaul University. He is also the co-founder of Omaha Insights.
Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt
12 - 14 Nov 2025
London
ERA Research
Kevin Mason
Kevin Mason
Managing Director
Kevin has led a team of industry experts since 1997, covering the space for institutional investors, hedge funds, and government clients in the U.S., Canada, and Europe. He is a regular speaker at conferences hosted by the Pulp and Paper Products Council, the Council of Forest Industries, the Western Wood Products Association, and several others. Kevin’s views are frequently quoted in Bloomberg, the Financial Times, and the National Post, as well as on various radio and television programmes.
Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech
17 - 19 Nov 2025
London
Revelare Partners
Andrew Peters
Andrew Peters
Co-Founder & Managing Partner
Andrew is a co-founder of Revelare Partners. He has more than 15 years of experience in sales, research development and sourcing investment ideas for institutional investors. Prior to Revelare, Andrew was the Managing Director of Sales at DeMatteo Research LLC from 2011 to 2023 working with the team to build and expand its client base. He began his career as an Institutional Salesperson at PCS Research Services in 2008. He received a B.A. in Financial Economics from the University of Rochester.
Fundamental US Healthcare Short Ideas
17 - 19 Nov 2025
London
Favus Institutional Research
Dr Elliot Favus
Dr Elliot Favus
CEO & Senior Analyst
Dr. Favus is a pharmaceutical equity research specialist with buyside and sellside experience, including Senior Analyst roles at Och Ziff and Lazard. Earlier in his career, Dr. Favus spent 10 years working on human genetics projects at Harvard Medical School and the University of Chicago.